TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | -0 | -3 | 2 | 2 | -1 | -6 | -1 |
| P | %wins | 50 | 50 | 50 | 50 | 50 | 25 | 46 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/11 19:43 | 8/11/11 | ARRY | Array Biopharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Lefkoff Kyle | CO | D | P | 11 | 2.22 | 1 | 5 | 11 | 50 | I | -49 | -25 | -25 | -21 | -3 | -10 | 0 | 3 | -2 | -6 | -11 | 16 | 14 | 105 | |
5/11/10 16:10 | 5/7/10 | ARRY | Array Biopharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Lefkoff Kyle | CO | D | P | 15 | 3.71 | 6 | 4 | 8 | 55 | M | -37 | 7 | 78 | 49 | 27 | -10 | -5 | -1 | 5 | 2 | -16 | -11 | -8 | -26 | |
11/13/08 19:47 | 11/13/08 | ARRY | Array Biopharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Lefkoff Kyle | CO | D | P | 10 | 3.28 | 1 | 3 | 6 | 51 | I | -73 | -70 | -48 | -59 | -52 | -19 | -32 | -16 | -10 | -9 | 10 | 13 | -18 | -52 | |
3/12/08 18:02 | 3/10/08 | ARRY | Array Biopharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Lefkoff Kyle | CO | D | P | 27 | 5.39 | 3 | 5 | 12 | 48 | M | -40 | -52 | -52 | -53 | -9 | 4 | 3 | -2 | 6 | 3 | 26 | -9 | 10 | -52 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |